Life Sciences

Finance breakthroughs for life sciences companies

For 20 years we've been helping world changers with transformational accounting, operations, and software.

We serve the office of the CFO

Financial Reporting and Accounting

Audit readiness
Financial statements
Debt and equity financings
License and collaboration agreements
Stock compensation
Clinical accruals
Inventories
CRO and CMO agreements
Research and development
Government grants
Consolidations

Public Company Services

IPO planning and readiness

Alternative exits (reverse mergers, de-SPACs)

PCAOB audit uplift

Quarterization

Prepare S-1

SEC comment letters, pre-clearances and waivers

SOX 404, part (a) and part (b) testing

Quarterly/annual reporting assistance

Carve-outs

Material weakness remediation

Restatements

Operational

Transaction processing, journal entries, reconciliations

Month-end close

Management/Board reporting

Close acceleration and improvements

Power users with deep expertise across financial systems

Policies and procedures

Historic accounting cleanup

FP&A (budgets, etc.)

Key agreement review and advice

Staff augmentation

Systems, AI, and Automation

Finance automation roadmap and design

ERP implementation (NetSuite, Workday, Rillet, Campfire, QuickBooks, etc.)

Point solutions (Zip, Coupa, Ramp, Brex, Netgain, etc.)

Close and financial reporting automation (FloQast, NetClose, Workiva, DFIN, InScope, etc.)

Integrations to external payroll, HR, QMS, PLM, and LIMS systems

System administration, management, and user support

A rare blend of boutique size and legendary experience

Breakthrough
Work

2K+

Companies Supported

High-Growth
Companies

$4.0T

Valuation of Clients Helped to IPO

Complex
Transactions

750+

M&A Deals and IPOs Supported

What our clients are saying

Melody Burcar

VP Finance, LENZ Therapeutics, Inc

"Connor Group offers the flexibility, technical depth, and reliability that lean finance teams depend on. What began as a SOX engagement quickly expanded into technical accounting and system implementations as our trust in their team grew. They now operate as a true extension of our team, consistently exceeding expectations"

April Yamada

Head of Finance Operations, AngioSafe

“Connor Group helped us build dynamic financial models, enhance scenario planning for commercialization, and increase transparency in departmental spending. Leadership gained clearer, real-time insights to inform strategic decisions and investor communications.”

Anonymous

VP Finance, biotechnology company

“Connor Group has been a trusted and reliable partner for many years. Their expertise allows us to operate efficiently while ensuring we have access to top-tier technical accounting knowledge. Their ability to seamlessly step in during critical periods and effectively manage auditor relationships has been particularly valuable. We consider Connor Group an essential extension of our accounting department.”

Ben Lundgren

Managing Director, Low Institute for Therapeutics | CEO, Gwen Bio

“We formed the Low Institute for Therapeutics and Gwen Bio only a few months ago. Connor Group was ready to engage day one to help us build and run our finance and accounting. They bring a full-service approach - banking, Quickbooks, payroll, purchases, credit cards, reimbursements and budgets, allowing me and my team to focus on our business. We've relied on their quality reporting to make our most critical decisions and have not been disappointed. They have brought structure and process to our financial systems while still retaining the agility required for any startup.”

Our commitment to life sciences

Expert teams in all life science cities

Connor Group was founded in the Bay Area in 2006 and has a significant presence in major life science markets, including Boston, New York/New Jersey, Southern California, and Seattle.

25-year focus on life science companies

Life science companies have been at our core from the outset, with as much as a third of our work and almost half the IPOs we’ve supported in the industry.

We help from startup to public

We serve the entire range of life science entities, from early-day startups to multi-billion market cap entities, including both public and private companies.

We've helped over 500 life sciences clients grow and transform